Associated Papers
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.
Rashidghamat E et al.
Journal of the American Academy of Dermatology, 2020
Select a paper to view details